Sabiia Seb
PortuguêsEspañolEnglish
Embrapa
        Busca avançada

Botão Atualizar


Botão Atualizar

Registro completo
Provedor de dados:  Nature Precedings
País:  United Kingdom
Título:  The association between having a household member with a cancer-related limitation and human papillomavirus vaccine uptake
Autores:  Tabatha N. Offutt-Powell
Rohit P. Ojha
Joseph Tota
Karan P. Singh
Data:  2010-09-20
Ano:  2010
Palavras-chave:  Bioinformatics
Resumo:  OBJECTIVE: To evaluate the association between having a household member with a cancer-related limitation (physical, mental, or emotional) and human papillomavirus (HPV) vaccine uptake among females aged 9 – 17 years. 
METHODS: We analyzed 2008 National Health Interview Survey for our cross-sectional analysis. All households with females aged 9 – 17 years were eligible for inclusion in our analysis. Our outcomes of interest included HPV vaccine initiation (≥1 dose) and series completion (full 3 doses). A dichotomous variable indicating a cancer-related limitation for a household member was created if at least one adult in the household responded to having a limitation caused by cancer. We used Firth’s bias-reducing penalized likelihood for logistic regression[11] to estimate prevalence odds ratios (ORs) and corresponding 95% profile penalized likelihood confidence intervals (CIs) for HPV vaccine uptake among young females who had a household member with a cancer-related limitation compared to young females who did not have a household member with a cancer-related limitation after adjusting for child’s age, race/ethnicity, and SES.
RESULTS: HPV vaccine initiation and completion were higher among females aged 9-17 years who had a household member with a cancer-related limitation (Initiation: OR=1.42, 95%CI: 0.26, 5.18); Completion: OR=2.50, 95%CI: 0.26, 11.58). 
CONCLUSION: Our results suggest that females aged 9 – 17 years in the United States who have a household member with a cancer-related limitation (physical, mental, or emotional) may be more likely to initiate and complete the HPV vaccination. However, our point estimates lack precision (evident by wide confidence intervals) because of limited prevalence of the exposure in our study population.

Tipo:  Manuscript
Identificador:  http://precedings.nature.com/documents/4925/version/1

oai:nature.com:10101/npre.2010.4925.1

http://hdl.handle.net/10101/npre.2010.4925.1
Fonte:  Nature Precedings
Direitos:  Creative Commons Attribution 3.0 License
Fechar
 

Empresa Brasileira de Pesquisa Agropecuária - Embrapa
Todos os direitos reservados, conforme Lei n° 9.610
Política de Privacidade
Área restrita

Embrapa
Parque Estação Biológica - PqEB s/n°
Brasília, DF - Brasil - CEP 70770-901
Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco

Valid HTML 4.01 Transitional